tiprankstipranks
Trending News
More News >
Enveric Biosciences (ENVB)
NASDAQ:ENVB
US Market

Enveric Biosciences (ENVB) Income Statement

Compare
566 Followers

Enveric Biosciences Income Statement

Last quarter (Q3 2025), Enveric Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Enveric Biosciences's net income was $-1.87M. See Enveric Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -337.49K$ -408.03K$ -435.20K$ -681.61K$ -120.87K
Operating Expenses
$ 9.29M$ 16.04M$ 19.53M$ 25.26M$ 5.50M
Depreciation and Amortization
$ 337.49K$ 408.03K$ 435.20K$ 681.61K$ 120.87K
EBITDA
$ -9.23M$ -16.85M$ -19.52M$ -55.74M$ -6.30M
Operating Income
$ -9.63M$ -16.45M$ -19.96M$ -25.94M$ -5.62M
Other Income/Expenses
$ 66.21K$ -814.38K$ 4.05K$ -30.49M$ -1.25M
Pretax Income
$ -9.57M$ -17.26M$ -19.96M$ -56.43M$ -6.86M
Net Income
$ -9.57M-$ -18.50M$ -48.98M$ -6.86M
Per Share Metrics
Basic EPS
$ -228.48$ -97.08$ -87.72$ -1.24K$ -666.00
Diluted EPS
$ -228.48$ -97.08$ -156.00$ -1.24K$ -666.00
Weighted Average Shares Outstanding
41.91K 210.63K 210.63K 39.36K 9.59K
Weighted Average Shares Outstanding (Diluted)
41.91K 179.92K 173.19K 39.36K 9.59K
Currency in USD

Enveric Biosciences Earnings and Revenue History